When we used anti-CD25 to deplete CD25-expressing Treg cells (Fig. 6d and Extended Data Fig. 8f), we observed that the enhanced tumor burden in Chatfl/fl; Cd4-cre mice was partially decreased (Fig. 6e,f). This evidence concerns the gene CD4 and neoplasm.